Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Fadiea Al-Aieshy"'
Autor:
Maria Berndtsson, Anton Pohanka, Mika Skeppholm, Faris Al-Khalili, Jovan P. Antovic, Rickard E. Malmström, Yuko Rönquist-Nii, Fadiea Al-Aieshy
Publikováno v:
European Journal of Clinical Pharmacology. 72:671-679
The one-dose daily regime of rivaroxaban could cause a pronounced variability in concentration and effect of which a deeper knowledge is warranted. This study aimed to evaluate the typical exposure range and effect of the direct factor Xa (FXa)-inhib
Autor:
Maria Berndtsson, Faris Al-Khalili, Rickard E. Malmström, Lisbeth Söderblom, Mika Skeppholm, Yuko Rönquist-Nii, Anton Pohanka, Jovan P. Antovic, Fadiea Al-Aieshy, Annika Y. Östlund
Publikováno v:
Thrombosis Research. 136:148-153
The direct factor-Xa inhibitor apixaban is approved e.g. for the prevention of stroke in patients with atrial fibrillation (AF). Although routine monitoring of apixaban therapy is currently not recommended, selective monitoring could be useful to opt
Autor:
Ronny Alcalai, Rickard E. Malmström, Ela Shai, Amit Ritter, Bruria Hirsh, Amit Lotan, Rokach, David Varon, Galia Spectre, Fadiea Al-Aieshy
Publikováno v:
Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy. 35:140-147
Study Objective To assess the effect of two selective serotonin reuptake inhibitors (SSRIs), fluvoxamine and citalopram, that markedly differ in their level of cytochrome P450 (CYP) 2C19 inhibition, on the laboratory response to clopidogrel, a prodru
Autor:
Anders, Helldén, Fadiea, Al-Aieshy, Pia, Bastholm-Rahmner, Ulf, Bergman, Lars L, Gustafsson, Susanne, Sjöviker, Anders, Söderström, Ingegerd, Odar-Cederlöf
Publikováno v:
Lakartidningen. 111(43)
Autor:
Fadiea, Al-Aieshy, Filip, Josephson
Publikováno v:
Lakartidningen. 105(24-25)
Autor:
Ulf Bergman, Fadiea Al-Aieshy, Anders Helldén, Pia Bastholm-Rahmner, Lars L. Gustafsson, Ingegerd Odar-Cederlöf, Susanne Sjöviker, Anders Söderström, Hans Höök
Publikováno v:
BMJ Open
Objectives To assess general practitioners (GPs) experience from the implementation and use of a renal computerised decision support system (CDSS) for drug dosing, developed for primary healthcare, integrated into the patient’s electronic health re